1 Kaiser Permanente Northwest, Clackamas, Oregon.
2 Kaiser Permanente Colorado, Aurora.
J Manag Care Spec Pharm. 2018 Nov;24(11):1130-1137. doi: 10.18553/jmcp.2018.24.11.1130.
There is increasing demand on pharmacist time within clinical pharmacy services, and pharmacy technicians are a crucial resource for expanding pharmacy practice.
To assess the safety and effectiveness of pharmacy technician management of stable, in-range international normalized ratio (INR) results compared with usual care.
This retrospective, longitudinal, noninferiority cohort study was conducted at an integrated health care delivery system with a centralized anticoagulation service. Adult patients receiving chronic warfarin therapy with therapeutic INR results over a 3-month period (i.e., 100% time in therapeutic range [TTR] during the 3 months before the index date) were eligible for referral to technician warfarin management between March 1, 2015, and December 31, 2015. Patients with similar INR control during the same period but not referred to technician management were included as comparators in the usual care group. A one-sided noninferiority margin for the technician management group was set to -2.5% for mean TTR. Propensity scoring was used in regression modeling via inverse probability of treatment weights to compare between-group differences to account for covariates that may have influenced assignment to the technician group. Finally, bleeding, thromboembolic, and mortality outcomes were compared.
1,840 and 1,116 patients were included in the technician and usual care groups, respectively. The mean age of included patients was 73.1 years, and the majority (77.9%) had received warfarin for > 3 years. TTR during follow-up was 83.3% and 77.7% in the technician and usual care groups, respectively (mean difference = 5.7%; 95% CI = 4.1%-7.2%). The risk of thromboembolism was similar between the technician and usual care groups (HR = 0.84; 95% CI = 0.17-4.22; P = 0.832); however, bleeding (HR = 0.60; 95% CI = 0.39-0.94; P = 0.026) and all-cause mortality (HR = 0.44; 95% CI = 0.25-0.77; P = 0.004) were lower in the technician group during follow-up.
Technician management of stable patients receiving chronic warfarin therapy within an integrated health care delivery system's centralized anticoagulation service was associated with noninferior TTR results compared with usual care pharmacist management.
This study was internally funded by the Kaiser Permanente Pharmacy Department. The study sponsor had no role in the study design, analysis, or interpretation. The authors have no relevant financial conflicts of interest to disclose.
临床药学服务对药剂师时间的需求不断增加,而药剂技术员是扩大药学实践的关键资源。
评估与常规护理相比,药剂技术员管理稳定、在范围内的国际标准化比值(INR)结果的安全性和有效性。
这项回顾性、纵向、非劣效性队列研究在一个具有集中抗凝服务的综合医疗保健提供系统中进行。在 3 个月的时间内(即,在指数日期前的 3 个月内,100%时间处于治疗范围内[TTR])接受慢性华法林治疗且 INR 结果具有治疗效果的成年患者有资格在 2015 年 3 月 1 日至 2015 年 12 月 31 日期间转介给技术员进行华法林管理。在同一时期具有类似 INR 控制但未转介给技术员管理的患者被纳入常规护理组作为对照组。为技术员管理组设定了单侧非劣效性边界为 -2.5%的平均 TTR。通过逆概率治疗权重的回归模型进行倾向评分,以比较组间差异,以考虑可能影响技术员组分配的协变量。最后,比较了出血、血栓栓塞和死亡率结果。
在技术员和常规护理组中分别纳入了 1840 名和 1116 名患者。纳入患者的平均年龄为 73.1 岁,大多数(77.9%)接受华法林治疗>3 年。在随访期间,技术员组和常规护理组的 TTR 分别为 83.3%和 77.7%(平均差异=5.7%;95%CI=4.1%-7.2%)。技术员组和常规护理组的血栓栓塞风险相似(HR=0.84;95%CI=0.17-4.22;P=0.832);然而,在随访期间,技术员组的出血(HR=0.60;95%CI=0.39-0.94;P=0.026)和全因死亡率(HR=0.44;95%CI=0.25-0.77;P=0.004)较低。
在综合医疗保健提供系统的集中抗凝服务中,对接受慢性华法林治疗的稳定患者进行技术员管理与常规护理药剂师管理相比,TTR 结果无差异。
这项研究由 Kaiser Permanente 药房部门内部资助。研究赞助商在研究设计、分析或解释方面没有任何作用。作者没有相关的财务利益冲突需要披露。